4 commercial payer policies list J2315. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
4 policies from 4 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J2315 |
|---|---|---|
| Alopecia Areata | Feb 16, 2024 | Covered |
| Policy | Effective | Status of J2315 |
|---|---|---|
| Naltrexone (Vivitrol)Effective 01/01/2019 - 12/01/2019 | Jan 1, 2019 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J2315 |
|---|---|---|
| Vivitrol (Naltrexone Extended-Release) Injection | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J2315 |
|---|---|---|
| Subcutaneous Implantable Naltrexone Pellets | Jan 1, 2026 | Covered |